These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36175132)

  • 1. Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide.
    Grimaldi M; Perino F; Moretta G; Antonelli F; Paradisi A; Ricci F; Abeni D; Didona B; Fania L
    Dermatol Ther; 2022 Nov; 35(11):e15864. PubMed ID: 36175132
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Rosai-Dorfman disease.
    Gaul M; Chang T
    Cutis; 2019 Mar; 103(3):171-173. PubMed ID: 31039225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosai-Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low-dose thalidomide therapy.
    Kalay Yildizhan I; Sanli H; Akay BN; Erol HM; Kuzu I; Kırmızı A; Cengiz Seval G
    Dermatol Ther; 2021 Jul; 34(4):e14988. PubMed ID: 33993590
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: A case report.
    Wan M; Ding A; Liu H; Ou J; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101879. PubMed ID: 32562733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Purely cutaneous Rosai-Dorfman disease].
    Plettenberg H; Artik S; Kuhn A; Megahed M; Ruzicka T; Kruse R
    Hautarzt; 2004 Oct; 55(10):969-71. PubMed ID: 15351867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosai-Dorfman disease successfully treated with thalidomide: A case report.
    Shahidi-Dadras M; Hamedani B; Niknezhad N; Ghilizadeh N
    Dermatol Ther; 2019 Sep; 32(5):e13005. PubMed ID: 31228316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide.
    Li X; Hong Y; An Q; Chen J; Wei H; Chen HD; Gao XH
    JAMA Dermatol; 2013 Aug; 149(8):992-3. PubMed ID: 23783880
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indolent firm reddish papules. Cutaneous Rosai-Dorfman disease].
    Bens G; Kerdraon R; De Kyvon JJ; Estève E
    Hautarzt; 2011 May; 62(5):384-7. PubMed ID: 21431448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional methotrexate used in cutaneous Rosai-Dorfman disease.
    Nieto-Benito LM; Suárez-Fernández RM; Baniandrés-Rodríguez O
    Med Clin (Barc); 2020 Dec; 155(12):564-565. PubMed ID: 31759691
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple nodules and plaques on the face and trunk. Cutaneous Rosai-Dorfman disease (RDD).
    Wartman DG; Perry A; Werchniak AE
    Arch Dermatol; 2006 Nov; 142(11):1501-6. PubMed ID: 17116845
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 16. Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.
    Rubinstein M; Assal A; Scherba M; Elman J; White R; Verma A; Strakhan M; Mohammadi F; Janakiram M
    Am J Hematol; 2016 Feb; 91(2):E1. PubMed ID: 26502013
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of cutaneous Rosai-Dorfman disease to topical and intralesional steroids.
    Satter EK; Graham BS; Steger JW
    Br J Dermatol; 2003 Sep; 149(3):672-4. PubMed ID: 14511018
    [No Abstract]   [Full Text] [Related]  

  • 18. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body.
    Jia J; Tian Q; Zhang H; Zheng Y
    Int J Dermatol; 2017 May; 56(5):576-578. PubMed ID: 28255989
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease.
    Hoyo-Muñoz A; Collado-Borrell R; Escudero-Vilaplana V; Bastos-Oreiro M; Herranz-Alonso A; Sanjurjo-Sáez M
    J Clin Pharm Ther; 2022 Apr; 47(4):548-551. PubMed ID: 34514634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Rosai-Dorfman disease following pneumococcal vaccination.
    Bassis AV; Fairley JA; Ameln RT; Swick BL
    J Am Acad Dermatol; 2011 Oct; 65(4):890-892. PubMed ID: 21920257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.